诚达药业跌6.13% 财通证券4天前给予增持评级

Group 1 - The core point of the article is that Chengda Pharmaceutical (301201.SZ) experienced a stock price decline of 6.13%, closing at 31.10 yuan [1] - Haitong Securities analyst Hua Ting published a report on November 1, 2023, recommending an "overweight" rating for Chengda Pharmaceutical, focusing on its transformation towards cell and gene therapy [1]